Form 8-K - Current report:
SEC Accession No. 0001437749-25-009255
Filing Date
2025-03-26
Accepted
2025-03-26 07:05:41
Documents
17
Period of Report
2025-03-25
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20250324_8k.htm   iXBRL 8-K 43281
2 EXHIBIT 99.1 ex_794033.htm EX-99.1 12103
7 cyclologo.jpg GRAPHIC 14765
8 rlogo.jpg GRAPHIC 3033
  Complete submission text file 0001437749-25-009255.txt   243103

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20250325.xsd EX-101.SCH 4062
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20250325_def.xml EX-101.DEF 13444
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20250325_lab.xml EX-101.LAB 17671
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20250325_pre.xml EX-101.PRE 13421
19 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20250324_8k_htm.xml XML 4803
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

EIN.: 593029743 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 25770105
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)